Xinyuan Guan - Search Results

Year	Number of Results
2002	8
2003	7
2004	14
2005	13
2006	6
2007	13
2008	13
2009	17
2010	19
2011	27
2012	22
2013	17
2014	19
2015	17
2016	23
2017	19
2018	19
2019	24
2020	28
2021	36
2022	30
2023	23
2024	9

1

Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications.

Lee TK, Guan XY, Ma S. Lee TK, et al. Nat Rev Gastroenterol Hepatol. 2022 Jan;19(1):26-44. doi: 10.1038/s41575-021-00508-3. Epub 2021 Sep 9. Nat Rev Gastroenterol Hepatol. 2022. PMID: 34504325 Review.

2

Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Esophageal Squamous Cell Carcinoma.

Jia Y, Zhang B, Zhang C, Kwong DL, Chang Z, Li S, Wang Z, Han H, Li J, Zhong Y, Sui X, Fu L, Guan X, Qin Y. Jia Y, et al. Among authors: guan x. Adv Sci (Weinh). 2023 Mar;10(7):e2204565. doi: 10.1002/advs.202204565. Epub 2023 Jan 29. Adv Sci (Weinh). 2023. PMID: 36709495 Free PMC article.

3

Targeting cancer-associated fibroblast-secreted WNT2 restores dendritic cell-mediated antitumour immunity.

Huang TX, Tan XY, Huang HS, Li YT, Liu BL, Liu KS, Chen X, Chen Z, Guan XY, Zou C, Fu L. Huang TX, et al. Gut. 2022 Feb;71(2):333-344. doi: 10.1136/gutjnl-2020-322924. Epub 2021 Mar 10. Gut. 2022. PMID: 33692094 Free PMC article.

4

N⁶-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis.

Chen RX, Chen X, Xia LP, Zhang JX, Pan ZZ, Ma XD, Han K, Chen JW, Judde JG, Deas O, Wang F, Ma NF, Guan X, Yun JP, Wang FW, Xu RH, Dan Xie. Chen RX, et al. Among authors: guan x. Nat Commun. 2019 Oct 16;10(1):4695. doi: 10.1038/s41467-019-12651-2. Nat Commun. 2019. PMID: 31619685 Free PMC article.

5

Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction.

Gong L, Luo J, Zhang Y, Yang Y, Li S, Fang X, Zhang B, Huang J, Chow LK, Chung D, Huang J, Huang C, Liu Q, Bai L, Tiu YC, Wu P, Wang Y, Tsao GS, Kwong DL, Lee AW, Dai W, Guan XY. Gong L, et al. Nat Commun. 2023 Apr 6;14(1):1912. doi: 10.1038/s41467-023-37614-6. Nat Commun. 2023. PMID: 37024479 Free PMC article.

6

Blockade of NMT1 enzymatic activity inhibits N-myristoylation of VILIP3 protein and suppresses liver cancer progression.

Tan XP, He Y, Yang J, Wei X, Fan YL, Zhang GG, Zhu YD, Li ZQ, Liao HX, Qin DJ, Guan XY, Li B. Tan XP, et al. Signal Transduct Target Ther. 2023 Jan 9;8(1):14. doi: 10.1038/s41392-022-01248-9. Signal Transduct Target Ther. 2023. PMID: 36617552 Free PMC article.

7

Comprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma.

Gong L, Kwong DL, Dai W, Wu P, Li S, Yan Q, Zhang Y, Zhang B, Fang X, Liu L, Luo M, Liu B, Chow LK, Chen Q, Huang J, Lee VH, Lam KO, Lo AW, Chen Z, Wang Y, Lee AW, Guan XY. Gong L, et al. Nat Commun. 2021 Mar 9;12(1):1540. doi: 10.1038/s41467-021-21795-z. Nat Commun. 2021. PMID: 33750785 Free PMC article.

8

FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.

Wang Y, Lyu Z, Qin Y, Wang X, Sun L, Zhang Y, Gong L, Wu S, Han S, Tang Y, Jia Y, Kwong DL, Kam N, Guan XY. Wang Y, et al. Theranostics. 2020 Sep 16;10(25):11535-11548. doi: 10.7150/thno.45261. eCollection 2020. Theranostics. 2020. PMID: 33052231 Free PMC article.

9

Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors.

Xu L, Zou C, Zhang S, Chu TSM, Zhang Y, Chen W, Zhao C, Yang L, Xu Z, Dong S, Yu H, Li B, Guan X, Hou Y, Kong FM. Xu L, et al. Among authors: guan x. J Hematol Oncol. 2022 Jul 7;15(1):87. doi: 10.1186/s13045-022-01307-2. J Hematol Oncol. 2022. PMID: 35799264 Free PMC article. Review.

10

Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer.

Jia Y, Yan Q, Zheng Y, Li L, Zhang B, Chang Z, Wang Z, Tang H, Qin Y, Guan XY. Jia Y, et al. J Exp Clin Cancer Res. 2022 Sep 29;41(1):287. doi: 10.1186/s13046-022-02449-4. J Exp Clin Cancer Res. 2022. PMID: 36171622 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

371 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

371 results

Results by year